pharmaphorum

JULY 27, 2021

Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of the company later this year. per share in the initial deal, which will give it a 64.6% stake in the company.

Drug Delivery 111

Drug Delivery Insulin Cosmetics Development 111

pharmaphorum

MAY 4, 2022

Leading experts from big pharma will be presenting case studies on recent advances in platform approaches in drug delivery devices and smart devices, while a panel discussion will explore the emerging opportunities of platforms for injectable devices. Who should attend: Drug-delivery developers. Medical Device Engineers.

Drug Delivery 52

Drug Delivery Packaging Packaging Engineer 52

pharmaphorum

JANUARY 18, 2022

The past year has seen significant developments in the injectables landscape with the rapid introduction and development of vaccines in response to the pandemic, updates in regulations including the EU MDR and FDA guidance on bridging studies, and increasing industry acceptance of connectivity to aid the user experience. Drug developers.

Drug Delivery 52

Drug Delivery Production Drug Delivery Systems Packaging 52

pharmaphorum

NOVEMBER 17, 2021

The Future of Drug Delivery and Combination Product Device Design. The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products.

Drugs 52

Drugs Drug Delivery Engineer Production 52

Roots Analysis

MARCH 8, 2023

Over time, various research studies have demonstrated the potential of exosomes ( membrane bound extracellular vesicles) in disease diagnosis, drug delivery and therapeutic applications. In addition, they are involved in regulating the expression of the targets that are linked to RNA as they can affect the expression of RNA.

RNA 52

RNA Drug Delivery DNA Development 52

Drug Discovery World

JUNE 7, 2023

s National Security and Investment Act, testimony to invoX’s continued willingness to build trust and work closely with regulators. McCarthy said: “At pHion Therapeutics, it is our mission to pioneer next generation, first-in-class vaccines for infectious disease and oncology through stealth-like delivery of mRNA.

Vaccination 52

Vaccination Vaccine Drug Delivery Systems Drug Delivery 52

Drug Discovery World

OCTOBER 5, 2022

In essence, manufacturing complex drugs with controlled drug delivery or release profile enhances the therapy that is based on the patient’s individual data. . RA: How regulated is bioprinting and is there more work needed with regulators to make it more accessible? .

Drugs 52

Drugs Regulation Manufacturing Medicine 52

Pharmaceutical Technology

OCTOBER 26, 2022

It indicates that nanomedicine also has the potential to combat the threat of antibiotic resistance via the use of nanomaterials with intrinsic antibacterial properties, as well as using nanoparticles as effective drug delivery systems for antibacterial agents.

Manufacturing 130

Manufacturing Drug Delivery Systems Contamination Drug Delivery 130

FDA Law Blog

MARCH 12, 2024

In fact, federal law and regulation appear to require AbbVie to list these patents.” Kaleo also delisted, but not without noting that “the decision to list each of these patents was proper, consistent, and required by the applicable statutes, regulations, and FDA’s guidance available at the time of listing.”

Drugs 59

Drugs Drug Delivery Systems Regulation Production 59

The Pharma Data

NOVEMBER 2, 2020

. “Psychedelic agents are a promising new class of therapeutic drug. We see a natural opportunity to apply XPhyto’s drug formulation expertise and Vektor’s proven drug delivery platforms to these emerging APIs,” said Hugh Rogers, CEO and Director of XPhyto. About XPhyto Therapeutics Corp.

Production 52

Production Development Drug Delivery Drugs 52

The Pharma Data

OCTOBER 27, 2020

On April 20, 2020, XPhyto announced a definitive development, technology purchase and licence agreement with 3a-Diagnostics for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a’s pathogen specific biosensors and XPhyto’s oral dissolvable drug delivery platform.

RNA 52

RNA Drug Delivery Production In-Vitro 52

The Pharma Data

DECEMBER 20, 2020

With this acquisition we are expanding our product pipeline to include psychedelic therapeutics, incorporating elements of our IP around drug delivery technology in which we already have prototypes developed, which we believe will propel us towards clinical studies relatively quickly. Ahmad Doroudian, CEO of BetterLife.

Drug Delivery 52

Drug Delivery Containment Production Development 52

Roots Analysis

OCTOBER 5, 2023

Driven by the increasing need for safe and efficient medical devices and drug delivery systems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. Vaccine Adjuvants: Polymers often serve as carriers for releasing the antigen and thereby regulating the immunological responses.

Manufacturing 40

Manufacturing Drug Delivery Systems Drug Delivery Packaging 40

XTalks

OCTOBER 27, 2021

Genentech’s ocular implant drug delivery system for treatment of macular degeneration has received approval from the US Food and Drug Administration (FDA). Susvimo delivers ranibizumab via a port delivery system into a surgically placed implant in the eye, allowing for continuous delivery of the drug.

Drug Delivery Systems 104

Drug Delivery Systems Drug Delivery FDA Approval Drugs 104

pharmaphorum

AUGUST 2, 2022

The switch to an injectable version of the drug could also help to extend the commercial lifespan for Tecentriq and reduce the impact when biosimilars of the IV version reach eventually reach the market – assuming of course Roche can persuade clinicians to switch.

Trials 105

Trials Marketing Drugs Pharma Companies 105

The Pharma Data

JANUARY 18, 2021

According to Health Canada, “the information currently available at the Controlled Substances Directorate, 2-bromo-LSD is NOT CONTROLLED under the Schedules to the Controlled Drugs and Substances Act.”. The full Forbes article can be accessed here. BetterLife Pharma Inc.

Containment 40

Containment Regulation Production Drug Delivery 40

pharmaphorum

JUNE 30, 2021

Chinese biotech CanSino Biologics said in April it was starting trials of an inhaled COVID-19 vaccine, while others looking at nasal or inhaled delivery include Cadogenix, Phage Novo Bio, Precision Virologics, and Immune System Regulation (ISR). The post Altimmune ditches nasal COVID vaccine on weak trial data appeared first on.

Vaccination 98

Vaccination Vaccine Trials Immune Response 98

The Pharma Data

DECEMBER 14, 2020

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. About BetterLife Pharma Inc. BetterLife Pharma Inc. For further information please visit www.abetterlifephama.com. About Transcend Biodynamics.

Drug Delivery 40

Drug Delivery Containment Manufacturing Drugs 40

The Pharma Data

DECEMBER 28, 2020

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. About BetterLife Pharma Inc. BetterLife Pharma Inc.

Containment 52

Containment Drug Delivery Compliance Marketing 52

FDA Law Blog

SEPTEMBER 19, 2023

It merely says that “[t]he Hatch-Waxman Act and FDA regulations set forth the criteria for listing patents in the Orange Book” and that “Brand manufacturers are responsible for ensuring their patents are properly listed.” But it is not always clear which types of patents are eligible for listing in the Orange Book.

Drugs 105

Drugs Branding Drug Delivery Systems Generic Drugs 105

The Pharma Data

NOVEMBER 9, 2020

is accelerating the next-generation drug delivery, diagnostic, and phytochemical investment opportunities: precision transdermal and oral dissolvable drug dosage forms; rapid, low-cost infectious disease and oral health screening tools; and validation of approved cannabinoid-based therapeutics focused on European markets.

Development 40

Development Drugs Drug Delivery Production 40

The Pharma Data

NOVEMBER 4, 2020

is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and phyto-therapeutic investment opportunities: precision transdermal and oral dissolvable drug dosage forms; rapid, low-cost infectious disease and oral health screening tools; and emerging plant-based therapeutics focused on European markets.

Drug Delivery 40

Drug Delivery Production Manufacturing Life Science 40

Drug Discovery World

OCTOBER 18, 2023

Such therapies have become an appealing drug modality for multiple conditions, including monogenic disorders, cancers, and infectious diseases. However, NHP models cannot fully predict AAV transduction in the human liver.

Gene Therapy 65

Gene Therapy Gene Clinical Trials Clinical Trials 65

XTalks

AUGUST 30, 2022

One of the biggest challenges with developing therapies to treat CNS disorders is the delivery of systemically administered investigational products (IPs) to the brain, which is limited by the blood-brain barrier. Some methods of direct CNS administration include intrathecal, intraparenchymal and intracerebroventricular (ICV) delivery.

Trials 83

Trials Drug Delivery Drugs Gene 83

XTalks

JULY 5, 2022

A corporate compliance training program is a part of many onboarding programs to ensure employees are up to date with the latest rules and regulations they must adhere to while working for the company. Clarification is key and the employees’ job requirements must be clearly communicated. Employee Compensation and Rewards.

Life Science 52

Life Science Compliance Packaging Packaging 52

XTalks

JUNE 15, 2022

The featured speakers will discuss how life science manufacturers can now save time, money and resources and increase time to market by doing away with fully customized QMS solutions — while remaining compliant with industry regulations and standards. Royal Philips has been researching and developing treatment for critical limb ischemia.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

The Pharma Data

JANUARY 3, 2021

The information in the press release is information that Nanoform is obliged to make public pursuant to the EU Market Abuse Regulation. . +46 7686 650 11. 1 Good Manufacturing Practice. 2 Proof of Concept. 3 Active Pharmaceutical Ingredient. Finnish time. About Nanoform. Nanoform is an innovative nanoparticle medicine enabling company.

Containment 52

Containment Bioavailability Clinical Trials Clinical Trials 52

The Pharma Data

JANUARY 16, 2021

Since its launch at the end of 2018, Etta’s X-Porator F1 has been accepted and adopted by many Chinese antibody drug and IVD benchmark companies, bringing significant benefits to customers. About JS Bio.

Protein 52

Protein Production Antibody In-Vitro 52

The Pharma Data

OCTOBER 27, 2020

The technology enhances the delivery of ingredients to and through the skin and is protected by patents in eleven countries. Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Sales 52

Sales Production Drug Delivery Development 52

The Pharma Data

JANUARY 17, 2021

Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this news release. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 pandemic. About XPhyto Therapeutics Corp.

Production 40

Production Drug Delivery Development Drugs 40

The Pharma Data

NOVEMBER 26, 2020

The information in the press release is information that Nanoform is obliged to make public pursuant to the EU Market Abuse Regulation. For investor relations queries, please contact: Henri von Haartman , Director of Investor Relations hvh@nanoform.com / +46 7686 650 11. Finnish time. About Nanoform.

Containment 52

Containment Medicine Bioavailability Clinical Trials 52

XTalks

MAY 30, 2023

The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. The patch itself is made of biodegradable nanocellulose and contains no plastic additives. Behfar, senior scientist at VTT, in the news release.

Drug Delivery 98

Drug Delivery Drug Delivery Systems Manufacturing Contamination 98

Delveinsight

FEBRUARY 14, 2021

The health regulatory agencies all over have issued several guidelines, released strategies, and amended regulations to expedite the drug delivery process in the rare disease market landscape.

Marketing 52

Marketing Clinical Trials Clinical Trials Trials 52

Delveinsight

JANUARY 22, 2021

TAK-755 (BAX930/SHP655) is a human recombinant ADAMTS13, the plasma metalloprotease that regulates the von Willebrand Factor (VWF) multimers. To sum it all, upcoming pipeline therapies in the Thrombocytopenia drugs market are based on novel mechanisms of action that aims to target several different Thrombocytopenia patient groups.

Marketing 65

Marketing Drugs Antibody Compliance 65

Delveinsight

SEPTEMBER 2, 2021

On August 18, 2021, Abiomed received breakthrough device designation from the United States Food and Drug Administration (FDA) for its Impella ECP expandable percutaneous heart pump , the world’s smallest heart pump and the first to be compatible with small-bore access and closure techniques.

Marketing 72

Marketing Radiology Drugs Drug Delivery 72

FDA Law Blog

JANUARY 5, 2023

Claud — As we turn into the New Year, we offer a few items of interest in digital and telehealth regulation, enforcement, and compliance that may provide some helpful guideposts for stakeholders. This was a topic at the December Food and Drug Law Institute conference on Current Developments in Digital Health Technology and Regulation.

Regulation 59

Regulation Production Drug Delivery Insulin 59

XTalks

AUGUST 24, 2022

By the end of this year, the EPA plans to propose an air pollution regulation to address EtO emissions at commercial sterilizers and to protect public health. As a result, the EPA is providing new information on specific facilities where lifetime risk levels are the largest to nearby communities.

Drug Delivery Systems 98

Drug Delivery Systems Drug Delivery Regulation Packaging 98